Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)
Clinical trial NCT04765657 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04765657
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-06-09
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.